rs141192321
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS1
The NM_018139.3(DNAAF2):c.1459C>T(p.Arg487Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000215 in 1,605,590 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_018139.3 missense
Scores
Clinical Significance
Conservation
Publications
- primary ciliary dyskinesia 10Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia, ClinGen
- primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -16 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| DNAAF2 | NM_018139.3 | c.1459C>T | p.Arg487Cys | missense_variant | Exon 1 of 3 | ENST00000298292.13 | NP_060609.2 | |
| DNAAF2 | NM_001083908.2 | c.1459C>T | p.Arg487Cys | missense_variant | Exon 1 of 2 | NP_001077377.1 | ||
| DNAAF2 | NM_001378453.1 | c.-413C>T | 5_prime_UTR_variant | Exon 1 of 2 | NP_001365382.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000933 AC: 142AN: 152144Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.000317 AC: 78AN: 245934 AF XY: 0.000217 show subpopulations
GnomAD4 exome AF: 0.000140 AC: 204AN: 1453328Hom.: 0 Cov.: 92 AF XY: 0.000115 AC XY: 83AN XY: 721802 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000933 AC: 142AN: 152262Hom.: 0 Cov.: 33 AF XY: 0.000900 AC XY: 67AN XY: 74448 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia Benign:2
This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
- -
DNAAF2-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at